Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review

Mandana KHODASHAHI, Zahra REZAIEYAZDI, Maryam SAHEBARI

DOI: 10.5606/ArchRheumatol.2020.7375

Issue: Volume 35 - Issue 1 - March 2020
2502 1889

Coexistence of Juvenile Systemic Lupus Erythematosus and Juvenile Spondyloarthropathy: A Case Report and Review of the Literature

Ayşe TANATAR, Ummihan TOPAL, Şerife GÜL KARADAĞ, Hafize Emine SÖNMEZ, Nuray AKTAY AYAZ

DOI: 10.5606/ArchRheumatol.2020.7468

Issue: Volume 35 - Issue 1 - March 2020
2629 1762

Fulminant Brain Atrophy and Vasculitis on Vessel-Wall Imaging in Neuropsychiatric Lupus: Case Report and Literature Review

Mihaela Ionela SARBU, Nicolae SARBU

DOI: 10.46497/ArchRheumatol.2020.7544

Issue: Volume 35 - Issue 3 - September 2020
1664 1887

Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus

Yaling CHEN, Yanqing WANG, Xiangfang CHEN, Huishun LIANG, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2020.7583

Issue: Volume 35 - Issue 2 - June 2020
2181 1604

Retrospective Analysis of the Factors Affecting Growth Parameters in Turkish Children With Systemic Lupus Erythematosus

Sibel BALCI, Rabia Miray KIŞLA EKİNCİ, Engin MELEK, Aysun KARABAY BAYAZIT, Dilek DOĞRUEL, Derya UFUK ALTINTAŞ, Mustafa YILMAZ

DOI: 10.46497/ArchRheumatol.2020.7573

Issue: Volume 35 - Issue 3 - September 2020
1719 1724

Platelet Distribution Width Level in Patients With Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension and Its Diagnostic Value

Yuzhu HE, Yikai YU, Shaoxian HU

DOI: 10.46497/ArchRheumatol.2020.7791

Issue: Volume 35 - Issue 3 - September 2020
1932 1546

Pattern of Nailfold Capillaroscopy in Patients With Systemic Lupus Erythematosus

Ting ZHAO, Fu-an LIN, Hong-pu CHEN

DOI: 10.46497/ArchRheumatol.2020.7763

Issue: Volume 35 - Issue 4 - December 2020
2910 1992

Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus

Waleed HASSAN, Eman BEHIRY, Marwa MAHGOUB

DOI: 10.46497/ArchRheumatol.2021.8001

Issue: Volume 36 - Issue 1 - March 2021
1239 2082

Imbalanced Innate Lymphoid Cells are Associated With Disease Activity and Arthritis Involvement in Patients With Systemic Lupus Erythematosus

Yanni JIANG, Yi ZHAO, Yi LIU, Qiaorong HUANG, Wentong MENG, Hong XU, Xianming MO

DOI: 10.46497/ArchRheumatol.2020.7440

Issue: Volume 35 - Issue 4 - December 2020
1617 1600

Experiences of Iranian female patients with systemic lupus erythematosus: A qualitative study

Zahra Behboodi MOGHADAM, Seyedeh Tahereh FAEZI, Armin ZAREIAN, Elham REZAEI

DOI: 10.46497/ArchRheumatol.2021.7989

Issue: Volume 36 - Issue 1 - March 2021
1143 1604

Association of vitamin D deficiency and disease activity in systemic lupus erythematosus patients: Two-year follow-up study

Ainan ARSHAD, Saad Bin Zafar MAHMOOD, Ahmed AYAZ, Adil Al Karim MANJI, Akash Kumar AHUJA

DOI: 10.46497/ArchRheumatol.2021.8178

Issue: Volume 36 - Issue 1 - March 2021
1534 1738

Factors associated with self-reported capacity to walk, jog and run in individuals with systemic lupus erythematosus

Gizem İrem KINIKLI, Susanne PETTERSSON, Sevilay KARAHAN, Iva GUNNARSSON, Elisabet SVENUNGSSON, Carina BOSTRÖM

DOI: 10.46497/ArchRheumatol.2021.8193

Issue: Volume 36 - Issue 1 - March 2021
1203 1793

Investigation of Genes Associated With Atherosclerosis in Patients With Systemic Lupus Erythematosus

Mehmet Ali BALCI, Engin ATLI, Hakan GüRKAN

DOI: 10.46497/ArchRheumatol.2021.8024

Issue: Volume 36 - Issue 2 - June 2021
1032 2063

Identification of sequence polymorphisms in the mitochondrial deoxyribonucleic acid displacement-loop region as risk factors for systemic lupus erythematosus

Ruixue Lai, Xiaoyun Zhang, Kuangyuan Qiao, Xueqing Gao, Shang Li, Ruixing Zhang, Yixin Qi, Chenxing Peng

DOI: 10.46497/ArchRheumatol.2021.8101

Issue: Volume 36 - Issue 3 - September 2021
1600 1639

Association of TNFAIP3 gene polymorphism (rs5029939) with susceptibility and clinical phenotype of systemic lupus erythematosus

Hala Gaballah, Reham Abd-elkhalek, Ola Hussein, Shimaa Abd El-wahab

DOI: 10.46497/ArchRheumatol.2022.8769

Issue: Volume 36 - Issue 4 - December 2021
976 1446

Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study

Sherif M Gamal, Nermeen Fouad, Nora Yosry, Wael Badr, Nesreen Sobhy

DOI: 10.46497/ArchRheumatol.2022.8888

Issue: Volume 37 - Issue 2 - June 2022
1433 1773

Thrombocytopenia in a cohort of primary and secondary antiphospholipid syndrome patients: Relation to clinical, laboratory manifestations and damage index

Sherif Gamal, Samar Mohamed, Abdelkawy Moghazy

DOI: 10.46497/ArchRheumatol.2022.9088

Issue: Volume 37 - Issue 2 - June 2022
991 1606

Therapeutic Effects of Tofacitinib on Pristane-Induced Murine Lupus

Jiayi LIN, Yaqin ZHANG, Meihua WANG, Yang ZHANG, Pin LI, Yingping CAO, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2022.8252

Issue: Volume 37 - Issue 2 - June 2022
1355 2136

Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic

Yasmin Adel, Mohamed Elgamal, Sherehan Adel Abdelsalam

DOI: 10.46497/ArchRheumatol.2022.8996

Issue: Volume 37 - Issue 2 - June 2022
1507 1752

A retrospective review of antiphospholipid syndrome from a South Asian country

Muhammad Zain Mushtaq, Syed Ahsan Ali, Zaibunnisa Sattar, Saad Bin Zafar Mahmood, Tazein Amber, Mehmood Riaz

DOI: 10.46497/ArchRheumatol.2022.8979

Issue: Volume 37 - Issue 1 - March 2022
1307 1257